La Jolla’s investigational therapy LJPC-401 (synthetic human hepcidin) to treat sickle cell disease has been recommended for orphan drug…
Articles by Margarida Azevedo, MSc
National and local policies have led to large reductions in lead poisoning cases overall in the U.S., but severe cases are still common…
For the first time, scientists were able to correct the genetic mutation that causes sickle cell disease in stem…
Mast Therpeutics has announced that the clinical development of Vepoloxamer (MST-188) is likely to be terminated. Results from…
In his keynote speech at a University of Miami symposium recently, Robert M. Califf, the U.S. Food and Drug Administration…
Engineers and computer scientists from the University of Washington (UW) have developed what they are calling a HemaApp, designed…
Sickle cell disease (SCD) is rampant in sub-Saharan Africa, a region that accounts for about two-thirds of all SCD births worldwide, and…
Researchers believe that activating a specific oxidative stress regulator with sulforaphane (SFN), a chemical compound found in vegetables such as broccoli and brussels sprouts,…
The Embrace Kids Foundation has committed $70,000 to support the expansion of Rutgers Robert Wood Johnson Medical School (RWJMS)…
The American Red Cross and Sports Clips Haircuts have partnered to increase blood and platelet donations across the U.S.,…